RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRVS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Corvus Pharmaceuticals stock price down 0.559% on Thursday
(Updated on Mar 28, 2024)

Sell candidate since Mar 08, 2024 Loss -16.04% PDF

The Corvus Pharmaceuticals stock price fell by -0.559% on the last day (Thursday, 28th Mar 2024) from $1.79 to $1.78. During the last trading day the stock fluctuated 4.99% from a day low at $1.76 to a day high of $1.85. The price has fallen in 5 of the last 10 days and is down by -5.32% for this period. Volume has increased on the last day by 113 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 273 thousand shares were bought and sold for approximately $485.30 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.75 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.68% during the next 3 months and, with a 90% probability hold a price between $1.65 and $2.16 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRVS Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, March 25, 2024, and so far it has risen 1.14%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Corvus Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.80 and $2.09. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Corvus Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Corvus Pharmaceuticals stock

Corvus Pharmaceuticals finds support from accumulated volume at $1.76 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0880 between high and low, or 4.99%. For the last week, the stock has had daily average volatility of 6.47%.

Corvus Pharmaceuticals is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRVS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Corvus Pharmaceuticals to open at $1.80, and during the day (based on 14 day Average True Range), to move between $1.64 and $1.92, which gives a possible trading interval of +/-$0.143 (+/-8.05%) up or down from last closing price. If Corvus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 16.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.79 (0.56%) than the support at $1.76 (1.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Corvus Pharmaceuticals stock A Buy?

Corvus Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.032 Sell Candidate Unchanged

Predicted Opening Price for Corvus Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$1.80 ( 0.97%) $1.78

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRVS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.89 5.92 %
R2 1.85 4.03 %
R1 1.83 2.86 %
Current price: 1.78
Support S1 1.76 -0.91 %
S2 1.74 -2.08 %
S3 1.71 -3.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.22 24.44 %
R2 2.11 18.54 %
R1 1.79 0.562 %
Current price 1.78
Support S1 1.76 -1.12%
S2 0 .
S3 0 .

FAQ

What is the symbol for Corvus Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Corvus Pharmaceuticals is CRVS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Corvus Pharmaceuticals Stock?
Corvus Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Corvus Pharmaceuticals Stock?
Corvus Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Corvus Pharmaceuticals Stock.

What's the current price of Corvus Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Corvus Pharmaceuticals (CRVS) share was $1.78.

What is the 52-week high and low for Corvus Pharmaceuticals Stock?
The 52-week high for Corvus Pharmaceuticals Stock is $4.19 and the 52-week low is $0.660.

What is the market capitalization of Corvus Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Corvus Pharmaceuticals is 87.289M.

When is the next earnings date for Corvus Pharmaceuticals?
The upcoming earnings date for Corvus Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About Corvus Pharmaceuticals

Corvus Pharmaceuticals Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat pa... CRVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT